Jun 2026 (Q2 FY26) — Aug 4, 2026
HealthStream Q2 FY26 — Record Revenue and Adjusted EBITDA Drive Increased Investments
Read the full callHealthStream (HSTM) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
HealthStream earnings: last reported Tue, 4 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 83.7 | +12.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 9.9 | +2.0 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 6.7 | +23.8% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$33.31 +0.54% · +$0.18
Performance +25.5% 1Y
1Y: $26.54 on 17 Oct 2025 → $33.31. High $33.75 (13 Oct 2026), low $19.88 (12 Feb 2026).
- Previous close
- $33.13
- 52-week range
- $19.88 – $33.75
- One year
- +23.42%
Overview
- Symbol
- HSTM
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
HealthStream earnings calls (HSTM)
Financials
What the filings say
Net profit, year on year: +24% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 73 | 74 | 73 | 74 | 76 | 80 | 81 | 84 |
| Expenses | 67 | 70 | 69 | 69 | 69 | 77 | 74 | 75 |
| Operating profit | 6 | 5 | 4 | 6 | 8 | 2 | 8 | 8 |
| Operating margin | 8.9% | 6.3% | 6.0% | 7.9% | 9.9% | 3.0% | 9.3% | 9.9% |
| Other income | 1 | — | — | — | — | — | — | — |
| Profit before tax | 7 | 5 | 5 | 7 | 8 | 3 | 8 | 9 |
| Tax rate | 23.4% | 10.8% | 17.4% | 21.5% | 26.3% | 11.1% | 24.4% | 23.3% |
| Net profit | 6 | 5 | 4 | 5 | 6 | 3 | 6 | 7 |
| EPS ($ per share) | 0.19 | — | 0.14 | 0.18 | 0.20 | — | 0.20 | 0.23 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 287 | 290 | 272 | 271 | 255 | 249 | 252 | 232 |
| Reserves | 32 | 48 | 62 | 68 | 80 | 92 | 109 | 124 |
| Total liabilities | 123 | 151 | 166 | 148 | 164 | 159 | 151 | 166 |
| Fixed assets | 16 | 26 | 22 | 18 | 15 | 13 | 11 | 11 |
| Total assets | 442 | 490 | 500 | 487 | 498 | 500 | 511 | 520 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 43 | 66 | 36 | 42 | 51 | 64 | 58 | 63 |
| Cash from investing | 37 | -68 | -110 | -26 | -28 | -57 | -34 | -50 |
| Cash from financing | -30 | -1 | -20 | -6 | -24 | -13 | -5 | -36 |
| Net cash flow | 50 | -3 | -95 | 10 | -1 | -6 | 19 | -23 |
| Capital expenditure | -7 | -22 | -2 | -3 | -2 | -2 | -1 | -4 |
| Free cash flow | 36 | 44 | 34 | 39 | 49 | 62 | 56 | 60 |
Insider filings
83 filings between Oct 30, 2025 and Sep 29, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$4.74M
8 sales by 5 insiders
38% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 2
- Award — granted as compensation
- 37
- Option exercise — converted options into shares
- 30
- Tax withheld — shares kept back by the company to cover tax
Also filed: 5 gifts, 1 disposition to issuer.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| FRIST ROBERT A JR | — | $4.25M | Sep 14, 2026 |
| REBROVICK LINDA | — | $274.0K | Jul 6, 2026 |
| O'Hara Kevin P | — | $120.7K | May 20, 2026 |
| Cunningham Jeff | — | $50.6K | Dec 10, 2025 |
| Taylor Tate Deborah | — | $40.2K | Nov 26, 2025 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 29, 2026 | O'Hara Kevin P Executive Vice President | Option exercise | 1,642 | $0 |
| Sep 29, 2026 | McQuigg Michael Scott Senior Vice President | Option exercise | 1,564 | $0 |
| Sep 29, 2026 | Roberts Scott Alexander CFO and SVP | Option exercise | 1,564 | $0 |
| Sep 29, 2026 | Collier Michael Manning Executive Vice President | Tax withheld | 477 | $13.9K |
| Sep 29, 2026 | LoPresto Jennifer Hayes Senior Vice President | Tax withheld | 134 | $3.9K |
| Sep 29, 2026 | Coady Trisha L Executive Vice President | Tax withheld | 400 | $11.6K |
| Sep 29, 2026 | McQuigg Michael Scott Senior Vice President | Tax withheld | 381 | $0 |
| Sep 29, 2026 | FRIST ROBERT A JR CEO and Chairman | Tax withheld | 477 | $13.9K |
| Sep 29, 2026 | Collier Michael Manning Executive Vice President | Option exercise | 1,955 | $0 |
| Sep 29, 2026 | LoPresto Jennifer Hayes Senior Vice President | Option exercise | 391 | $0 |
| Sep 29, 2026 | Roberts Scott Alexander CFO and SVP | Tax withheld | 381 | $11.1K |
| Sep 29, 2026 | Cunningham Jeff Chief Technology Officer | Tax withheld | 381 | $11.1K |
| Sep 29, 2026 | Cunningham Jeff Chief Technology Officer | Option exercise | 1,564 | $0 |
| Sep 29, 2026 | Coady Trisha L Executive Vice President | Option exercise | 1,642 | $0 |
| Sep 29, 2026 | FRIST ROBERT A JR CEO and Chairman | Option exercise | 1,955 | $0 |
| Sep 29, 2026 | O'Hara Kevin P Executive Vice President | Tax withheld | 400 | $11.6K |
| Sep 14, 2026 | FRIST ROBERT A JR CEO and Chairman | Sale | 144,068 | $4.25M |
| Jul 6, 2026 | REBROVICK LINDA Director | Sale 10b5-1 plan | 6,000 | $174.0K |
| Jun 8, 2026 | Taylor Tate Deborah Director | Option exercise | 3,148 | $0 |
| Jun 8, 2026 | MCLAREN JEFFREY L Director | Option exercise | 3,148 | $0 |
| Jun 8, 2026 | Beard Charles Jr. Director | Option exercise | 1,249 | $0 |
| Jun 8, 2026 | Jahangir Amir Alex Director | Option exercise | 3,148 | $0 |
| Jun 8, 2026 | RAPPUHN TERRY ALLISON Director | Option exercise | 3,148 | $0 |
| Jun 8, 2026 | DENT THOMPSON Director | Option exercise | 3,148 | $0 |
| Jun 8, 2026 | GORDON FRANK Director | Option exercise | 3,148 | $0 |
| Jun 8, 2026 | REBROVICK LINDA Director | Award | 3,148 | $0 |
| Jun 1, 2026 | REBROVICK LINDA Director | Sale 10b5-1 plan | 2,000 | $50.0K |
| May 28, 2026 | REBROVICK LINDA Director | Sale 10b5-1 plan | 2,000 | $50.0K |
| May 28, 2026 | GORDON FRANK Director | Award | 1,482 | $36.5K |
| May 20, 2026 | O'Hara Kevin P Executive Vice President | Sale | 3,000 | $72.2K |
| Mar 30, 2026 | Coady Trisha L Executive Vice President | Tax withheld | 1,382 | $29.4K |
| Mar 30, 2026 | Coady Trisha L Executive Vice President | Option exercise | 5,672 | $0 |
| Mar 30, 2026 | Collier Michael Manning Executive Vice President | Tax withheld | 1,774 | $37.7K |
| Mar 30, 2026 | Collier Michael Manning Executive Vice President | Option exercise | 7,285 | $0 |
| Mar 30, 2026 | McQuigg Michael Scott Senior Vice President | Option exercise | 5,601 | $0 |
| Mar 30, 2026 | Roberts Scott Alexander CFO and SVP | Option exercise | 5,601 | $0 |
| Mar 30, 2026 | McQuigg Michael Scott Senior Vice President | Tax withheld | 1,364 | $29.0K |
| Mar 30, 2026 | O'Hara Kevin P Executive Vice President | Tax withheld | 1,382 | $29.4K |
| Mar 30, 2026 | LoPresto Jennifer Hayes Senior Vice President | Tax withheld | 274 | $5.8K |
| Mar 30, 2026 | LoPresto Jennifer Hayes Senior Vice President | Option exercise | 803 | $0 |
| Mar 30, 2026 | FRIST ROBERT A JR CEO and Chairman | Tax withheld | 984 | $20.9K |
| Mar 30, 2026 | FRIST ROBERT A JR CEO and Chairman | Option exercise | 4,038 | $0 |
| Mar 30, 2026 | Cunningham Jeff Chief Technology Officer | Tax withheld | 1,364 | $29.0K |
| Mar 30, 2026 | Cunningham Jeff Chief Technology Officer | Option exercise | 5,601 | $0 |
| Mar 30, 2026 | O'Hara Kevin P Executive Vice President | Option exercise | 5,672 | $0 |
| Mar 30, 2026 | Roberts Scott Alexander CFO and SVP | Tax withheld | 1,364 | $29.0K |
| Feb 27, 2026 | Roberts Scott Alexander CFO and SVP | Option exercise | 2,541 | $0 |
| Feb 27, 2026 | Roberts Scott Alexander CFO and SVP | Tax withheld | 754 | $16.7K |
| Feb 27, 2026 | Coady Trisha L Executive Vice President | Tax withheld | 1,128 | $24.9K |
| Feb 27, 2026 | Coady Trisha L Executive Vice President | Option exercise | 3,803 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for HEALTHSTREAM INC
Free account. Everything above stays public.
Write why you follow HEALTHSTREAM INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading